会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • SYSTEM AND METHOD FOR IN VITRO ANALYSIS OF THERAPEUTIC AGENTS
    • 用于治疗药物的体外分析系统和方法
    • WO2002059599A2
    • 2002-08-01
    • PCT/US2002/002223
    • 2002-01-25
    • SMITHKLINE BEECHAM CORPORATIONWALKER, Dwight, SherodPATRICK, Mark, Austin
    • WALKER, Dwight, SherodPATRICK, Mark, Austin
    • G01N33/487
    • G01N21/05G01N21/31
    • A system and method for in vitro analysis of therapeutic agents comprising a reservoir adapted to hold a therapeutic agent, a first flow cell having a first cell chamber adapted to receive at least a first sample of the therapeutic agent, a second flow cell having a second cell chamber adapted to receive at least a second sample of the therapeutic agent, the first flow cell having a first path length (b e ') and the second flow cell having a second path length (b e "), the first path length being substantially equal to a sensitivity factor (f) x b e ", a membrane chamber having a biological cell membrane therein adapted to receive at least a third sample of the therapeutic agent, the membrane chamber being further adapted to detect the membrane potential of the biological cell membrane; and spectroscopic detection means for detecting the spectral characteristics of the first and second therapeutic agent samples.
    • 一种用于体外分析治疗剂的系统和方法,所述治疗剂包括适于保持治疗剂的储存器,具有适于接收所述治疗剂的至少第一样品的第一细胞室的第一流动池,具有第二流体池 所述第一流动池具有第一路径长度(be'),所述第二流动池具有第二路径长度(be“),所述第一路径长度基本相等 对于敏感性因子(f)x为“,具有其中适于接收至少第三样品的治疗剂的生物细胞膜的膜室,所述膜室还适于检测所述生物细胞膜的膜电位; 以及用于检测第一和第二治疗剂样品的光谱特性的光谱检测装置。
    • 10. 发明申请
    • METHOD AND SYSTEM FOR CHEMICAL SPECIFIC SPECTRAL ANALYSIS
    • 化学光谱分析方法与系统
    • WO2007098392A3
    • 2008-09-18
    • PCT/US2007062294
    • 2007-02-16
    • GLAXO GROUP LTDWALKER DWIGHT SHEROD
    • WALKER DWIGHT SHEROD
    • G01J5/02
    • G01N21/359G01N21/3563G01N21/3577
    • A method for chemical specific spectral analysis of a pharmaceutical composition (100) comprising the steps of transmitting light having a wavelength in the range of 800 - 2500 nm to a pharmaceutical composition, whereby the pharmaceutical composition interacts with the transmitted light, the interaction including the emission of a first light, directing the first light to a first multi-optical element (14) adapted to selectively pass a predetermined first fraction of the first light to pass there through, the first light fraction corresponding to the absorbance spectrum of an active contained in the pharmaceutical composition, and directing the first light fraction to a first NIR camera (16a) adapted to receive the first light fraction and provide a first NIR image of the pharmaceutical composition.
    • 一种用于药物组合物(100)的化学特异性光谱分析的方法,包括以下步骤:将波长在800-2500nm范围内的光透射到药物组合物,由此药物组合物与透射光相互作用,包括 发射第一光,将第一光引导到适于选择性地通过第一光的预定第一部分以通过其中的第一多光学元件(14),与包含的活性物质的吸收光谱相对应的第一轻馏分 并且将第一轻馏分引导到适于接收第一轻馏分并提供药物组合物的第一近红外图像的第一近红外照相机(16a)。